American Journal of Respiratory and Critical Care Medicine · 1999 · 139 citations · 28 references
Life SciencesNeurosciencePharmacologyHypersensitivityNeuroimmunologyNeuropharmacologyRespiratory PathophysiologyRespiratory PharmacologyAirway Hyperresponsiveness AssessmentAirway SensitivityAirway Smooth Muscle FunctionAsthma PathophysiologyNerve Growth Factor SignalingRespiratory Response
Because asthmatic patients show increased nerve growth factor (NGF) serum levels, we examined the effect of NGF on airway function. Intravenously administered NGF potentiates the histamine- induced bronchoconstriction with a maximum of over 200% in anesthetized spontaneously breathing guinea pigs. Doses of 8 ng and 80 ng NGF/kg body weight induce a significant hyperresponsiveness to histamine. NGF itself does not affect airway reactivity. Airway hyperresponsiveness is observed 30 min and 3 h after NGF administration, and has disappeared after 24 h. The neurokinin-1 receptor antagonist SR 140333 completely blocks the NGF-induced hyperresponsiveness, pointing to a role for tachykinins. This is the first report showing a direct relation between peripherally administered NGF and airway hyperresponsiveness. Taking into consideration that plasma NGF levels have been shown to be elevated in asthmatic patients, our result points to an important role for NGF in the pathogenesis of asthma.
28